Halo Genomics AB - Ownership and Business Overview

Life ScienceCompany

Halo Genomics AB Ownership

Who owns Halo Genomics AB?

Halo Genomics AB is owned by Agilent Technologies. It was acquired on December 1, 2011.

Halo Genomics AB Business Overview

Where is Halo Genomics AB headquartered?

Halo Genomics AB is headquartered in Uppsala, Sweden.

What sector is Halo Genomics AB in?

Halo Genomics AB is a life science company.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Subscribe to Mergr to view all 172 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 149 by strategics.

Halo Genomics AB

Dag Hammarskjölds väg 54A,
Uppsala, 751 83
Sweden,

Halo Genomics is a provider of technology for the next-generation DNA sequencing market. Halo Genomics' technology addresses sequence-selective sample preparation in next-generation sequencing. The company's HaloPlex technology combines the speed and specificity of polymerase chain reaction-based systems with the scalability and capture-size flexibility of solution-based hybridization formats, thus eliminating the need for library preparation.


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Halo Genomics AB

Life Science Companies